These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22434700)

  • 1. Factors affecting time required to reach maintenance dose during subcutaneous immunotherapy.
    Jourdy DN; Reisacher WR
    Int Forum Allergy Rhinol; 2012; 2(4):294-9. PubMed ID: 22434700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010.
    Santos N; Pereira AM; Silva R; Torres da Costa J; Plácido JL
    Allergol Immunopathol (Madr); 2015; 43(1):25-31. PubMed ID: 24661594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy.
    Hsu NM; Reisacher WR
    Int Forum Allergy Rhinol; 2012; 2(4):280-4. PubMed ID: 22434716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy.
    Leader BA; Rotella M; Stillman L; DelGaudio JM; Patel ZM; Wise SK
    Int Forum Allergy Rhinol; 2016 May; 6(5):460-4. PubMed ID: 26718480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.
    Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA
    Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
    Petersen KD; Gyrd-Hansen D; Linneberg A; Dahl R; Larsen JN; Løwenstein H; Kronborg C
    Int J Technol Assess Health Care; 2010 Jan; 26(1):20-9. PubMed ID: 20059777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A look at adherence with subcutaneous immunotherapy without out-of-pocket patient costs.
    Mendoza J; Carlson G; Nath P; Quinn J
    Ann Allergy Asthma Immunol; 2023 Jul; 131(1):96-100. PubMed ID: 37023983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.
    Rosewich M; Arendt S; El Moussaoui S; Schulze J; Schubert R; Zielen S
    Pediatr Allergy Immunol; 2013 Aug; 24(5):434-40. PubMed ID: 23578317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo sensitization during subcutaneous allergen specific immunotherapy - an analysis of 51 cases of SCIT and 33 symptomatically treated controls.
    Gellrich D; Eder K; Högerle C; Becker S; Canis M; Gröger M
    Sci Rep; 2020 Apr; 10(1):6048. PubMed ID: 32269269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.
    Cox L; Calderón M; Pfaar O
    Immunotherapy; 2012 Jun; 4(6):601-16. PubMed ID: 22788128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite.
    Baris S; Kiykim A; Ozen A; Tulunay A; Karakoc-Aydiner E; Barlan IB
    Allergy; 2014 Feb; 69(2):246-53. PubMed ID: 24180595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.